Proton Spectroscopy and Imaging at 3T in Ataxia-Telangiectasia

References

1. ↵
   Gatti RA, Berkel I, Boder E, et al. Localization of an ataxia-telangiectasia gene to chromosome 11q22–23. Nature 1998;336:577–78
2. Lange E, Borresen AL, Chen X, et al. Localization of an ataxia-telangiectasia gene to an approximately 500-kb interval on chromosome 11q23.1: linkage analysis of 176 families by an international consortium. Am J Hum Genet 1995;57:112–19

   PubMed
3. ↵
   Savitsky K, Bar-Shira A, Gilad S, et al. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 1995;268:1749–53

   Abstract/FREE Full Text
4. ↵
   Olsen JH, Hahnemann JM, Børresen-Dale A-L, et al. Cancer in patients with ataxia-telangiectasia and in their relatives in the Nordic countries. J Natl Cancer Inst 2001;93:121–27

   Abstract/FREE Full Text
5. ↵
   Jabado N, Concannon P, Gatti RA. Ataxia-telangiectasia, a neurodegenerative disorder. In: T Klockgether, ed. Handbook of Ataxia Disorders. New York: Marcel Dekker;2000 :163–90
6. ↵
   Lederman HM, Crawford TO (2002) Handbook for families and caregivers. In: A-T Children’s Project [online]. Available at: http://www.atcp.org/Handbook%20TOC.htm. Accessed January 2006
7. ↵
   Farr AK, Shalev B, Crawford TO, et al. Ocular manifestations of ataxia-telangiectasia. Am J Ophthalmol 2002;134:891–95

   CrossRefPubMedWeb of Science
8. ↵
   Solitaire GB. Louis-Bar’s syndrome (ataxia-telangiectasia). Neurology 1968;18:1180–86

   FREE Full Text
9. Nowak-Wegryzn A, Crawford TO, Winkelstein JA, et al. Immunodeficiency and infections in ataxia-telangiectasia. J Pediatr 2003;144:505–11
10. ↵
    Woods CG, Taylor AM. Ataxia telangiectasia in the British Isles: the clinical and laboratory features of 70 affected individuals. Q J Med 1992;82:169–79

    Abstract/FREE Full Text
11. ↵
    Taylor AM, Metcalfe JA, Thick J, et al. Leukemia and lymphoma in ataxia telangiectasia. Blood 1996;87:423–38

    Abstract/FREE Full Text
12. ↵
    Shiloh Y. Ataxia telangiectasia and the Nijmegen breakage syndrome: related disorders but genes apart. Annu Rev Genet 1997;31:635–62

    CrossRefPubMedWeb of Science
13. ↵
    Osborne AG, ed. Diagnostic Neuroradiology. St. Louis: Mosby-Year Book;1994 :309–11
14. ↵
    Vanhamme L, van den Boogaart A, van Huffel S. Improved methods for accurate and efficient quantification of MRS data with use of prior knowledge. J Magn Reson 1997;129:35–43

    CrossRefPubMedWeb of Science
15. ↵
    de Beer R, van Ormondt D. Analysis of NMR data using time domain fitting procedures. In: Rudin M, ed. NMR Basic Principles and Progress. Vol26 . Berlin: Springer-Verlag;1992 :201–48
16. ↵
    Perlman S, Becker-Catalina S, Gatti R. Ataxia-telangiectasia: diagnosis and treatment. Semin Pediatr Neurol 2003;10:173–82

    CrossRefPubMed
17. ↵
    Gatti RA, Vinters HV. Cerebellar pathology in ataxia-telangiectasia: the significance of basket cells. Kroc Found Ser 1985;19:225–32

    PubMed
18. ↵
    Demaerel PH, Kendall BE, Kingsley D. Cranial CT and MRI in diseases with DNA repair defects. Neuroradiology 1992;34:117–21

    CrossRefPubMed
19. ↵
    Farina L, Uggetti C, Ottolini A, et al. Ataxia-telangiectasia: MR and CT findings. J Comput Assist Tomogr 1994;18:724–27

    CrossRefPubMedWeb of Science
20. ↵
    Sardanelli F, Parodi RC, Ottonello C, et al. Cranial MRI in ataxia-telangiectasia. Neuroradiology 1995;37:77–82

    CrossRefPubMedWeb of Science
21. ↵
    Tavani F, Zimmerman RA, Berry GT, et al. Ataxia-telangiectasia: the pattern of cerebellar atrophy on MRI. Neuroradiology 2003;45:315–19

    PubMedWeb of Science
22. ↵
    Barr RM, Dillon WP, Wilson CB. Slow-flow vascular malformations of the pons: capillary telangiectasias? AJNR Am J Neuroradiol 1996;17:71–78

    Abstract
23. ↵
    Lee RR, Becher MW, Benson ML, et al. Brain capillary telangiectasia: MR imaging appearance and clinicohistopathologic findings. Neuroradiology 1997;205:797–805
24. ↵
    Ciemins JJ, Horowitz AL. Abnormal white matter signal in ataxia-telangiectasia. AJNR Am J Neuroradiol 2000;21:1483–85

    Abstract/FREE Full Text
25. ↵
    Huddle DC, Chaloupka JC, Sehgal V. Clinically aggressive diffuse capillary telangiectasia of the brain stem: a clinical radiologic-pathologic case study. AJNR Am J Neuroradiol 1999;20:1674–77

    Abstract/FREE Full Text
26. ↵
    Wilkinson ID, Paley M, Chong WK, et al. Proton spectroscopy in HIV infection: relaxation times of cerebral metabolites. Magn Res Imag 1994;12:951–57
27. ↵
    Viau M, Boulanger Y. Characterization of ataxias with magnetic resonance imaging and spectroscopy. Parkinsonism Relat Disord 2004;10:335–51

    CrossRefPubMedWeb of Science
28. ↵
    Guerrini L, Lolli F, Ginestroni A, et al. Brainstem degeneration correlates with clinical dysfunction in SCA1 but not SCA2. A qualitative volumetric, diffusion and proton spectroscopic MR study. Brain 2004;127:1785–95

    Abstract/FREE Full Text
29. ↵
    Wilkinson ID, Hadjivassiliou M, Dickson JM, et al. Cerebellar abnormalities on proton MR spectroscopy in gluten ataxia. J Neurol Neurosurg Psychiatry 2005;76:1011–13

    Abstract/FREE Full Text
30. ↵
    Mascalchi M, Cosottini M, Lolli F, et al. Proton MR spectroscopy of the cerebellum and pons in patients with degenerative ataxia. Radiology 2002;223:371–78

    CrossRefPubMedWeb of Science
31. ↵
    Castillo M, Kwock L, Mukherji SK. Clinical applications of proton MR spectroscopy. AJNR Am J Neuroradiol 1996;17:1–15

    PubMed
32. ↵
    Ross B, Bluml S. Magnetic resonance spectroscopy of the human brain. Anat Rec 2001;265:54–84

    CrossRefPubMed
33. ↵
    Perry TL, Kish SJ, Hinton D, et al. Neurochemical abnormalities in a patient with ataxia-telangiectasia. Neurology 1984;34:187–91

    Abstract/FREE Full Text
34. ↵
    Soher BJ, van Zijl PC, Duyn JH, et al. Quantitative proton MR spectroscopic imaging of the human brain. Magn Res Med 1996;35:356–63

    PubMedWeb of Science
35. ↵
    Burtscher IM, Holtås S. Proton MR spectroscopy in clinical routine. J Magn Res Imag 2001;13:560–67

    CrossRefPubMed
36. ↵
    Larnaout A, Belal S, Ben Hamida C, et al. Atypical ataxia telangiectasias with early childhood lower motor neuron degeneration: a clinicopathological observation in three siblings. J Neurol 1998;245:231–35

    PubMed
37. ↵
    Paula-Barbosa MM, Ruela C, Tavares MA, et al. Cerebellar cortex ultrastructure in ataxia-telangiectasia. Ann Neurol 1983;13:297–302

    CrossRefPubMedWeb of Science
38. ↵
    Gill SS, Small RK, Thomas DG, et al. Brain metabolites as 1H NMR markers of neuronal and glial disorders. NMR Biomed 1989;2:196–200

    PubMed
39. ↵
    Lai PH, Chen PC, Chang MH, et al. In vivo proton MR spectroscopy of chorea-ballismus in diabetes mellitus. Neuroradiology 2001;43:525–31

    CrossRefPubMed
40. ↵
    Scarabino T, Popolizio T, Bertolino A, et al. Proton magnetic resonance spectroscopy of the brain in pediatric patients. Eur J Radiol 1999;30:142–53

    CrossRefPubMed
41. ↵
    Wilson JX. Antioxidant defense of the brain: a role for astrocytes. Can J Physiol Pharmacol 1997;75:1149–63

    CrossRefPubMedWeb of Science
42. ↵
    Iida T, Furuta A, Nakabeppu Y, et al. Defense mechanism to oxidative DNA damage in glial cells. Neuropathology 2004;24:125–30

    PubMed
43. ↵
    Rotman G, Shiloh Y. ATM: from gene to function. Hum Mol Genet 1998;7:1555–63

    Abstract/FREE Full Text
44. ↵
    Watters DJ. Oxidative stress in ataxia-telangiectasia. Redox Rep 2002;8:23–29

    PubMed